Y-Intercept (HK)
EWTX icon

Y-Intercept (HK)’s Edgewise Therapeutics EWTX Stock Holding History

Y-Intercept (HK)’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-5,466
Closed -$222K – 1724
2026
Q2 		$222K Buy
+5,466
New +$188K ﹤0.01% 1538
2026
Q1 		– Sell
-18,672
Closed -$463K – 1698
2025
Q4 		$463K Sell
18,672
-38,628
-67% -$775K 0.01% 1255
2025
Q3 		$929K Buy
+57,300
New +$813K 0.02% 1010
2024
Q3 		– Sell
-13,701
Closed -$247K – 1462
2024
Q2 		$247K Sell
13,701
-1,202
-8% -$21K 0.01% 1096
2024
Q1 		$272K Buy
+14,903
New +$237K 0.02% 996

Other funds holding EWTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Quantum Private Wealth
Quantum Private Wealth Tampa, Florida $391M AUM 50.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Y-Intercept (HK)'s EWTX Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Edgewise Therapeutics (EWTX) in Q3 2026, closing a stake of 5,466 shares — an estimated $222K sold.

Y-Intercept (HK) first reported a position in EWTX in Q1 2024 and held it in 5 quarters. The position peaked at $929K in Q3 2025. 19 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Edgewise Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 5,466 Edgewise Therapeutics shares in Q3 2026, an estimated $222K.
  • Y-Intercept (HK) first reported a position in Edgewise Therapeutics in Q1 2024 and held it in 5 quarters.
  • Y-Intercept (HK)'s Edgewise Therapeutics position peaked at $929K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.